CG MedTech Co

CG MedTech Co Stock-Based Compensation

The Stock-Based Compensation (SBC) of CG MedTech Co (056090.KQ) as of Nov 19, 2026 is 75.42 M KRW. In the previous year, Stock-Based Compensation (SBC) was 59.62 M KRW — a change of 26.49% (higher).

Stock-Based Compensation

75.42 MKRW

YoY

26.49%

Last updated:

Stock-Based Compensation (SBC) of CG MedTech Co is 2024 75.42 M KRW. Stock-Based Compensation (SBC) of CG MedTech Co was 2023 59.62 M KRW. It decreases by 26.49% higher compared to the previous year.

The CG MedTech Co Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2022
9.54 M KRW
Jan 1, 2023
59.62 M KRW
Jan 1, 2024
75.42 M KRW
The CG MedTech Co Stock-Based Compensation history
YEARStock-Based CompensationYoY
75.42 MKRW+26.49%
59.62 MKRW+524.73%
9.54 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Stock-Based Compensation (SBC) of CG MedTech Co is 75.42 M KRW in 2024.

Stock-Based Compensation (SBC) of CG MedTech Co changed from 59.62 M KRW to 75.42 M KRW, representing a 26.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s CG MedTech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CG MedTech Co

All Key Metrics — CG MedTech Co